Eneli Ihuoma, Sadri Katayoun, Camargo Carlos, Barr R Graham
Department of Pediatrics and Human Development, Michigan State University, B220 Clinical Center Bldg, East Lansing, MI 48824-1313, USA.
Chest. 2005 Feb;127(2):604-12. doi: 10.1378/chest.127.2.604.
The prevalence of asthma has increased worldwide. The reasons for this rise remain unclear. Various studies have reported an association between acetaminophen, a widely used analgesic, and diagnosed asthma. In a prospective cohort study, the rate of newly diagnosed asthma was 63% higher among frequent acetaminophen users than nonusers in multivariate analyses. Studies of patients with asthma suggest that acetaminophen challenge can precipitate a decline in FEV(1) > 15% among sensitive individuals. Plausible mechanisms to explain this association include depletion of pulmonary glutathione and oxidative stress. This article reviews the existing literature and evaluates the epidemiologic and pathophysiologic evidence underlying a possible link between acetaminophen and asthma.
全球哮喘患病率呈上升趋势。其上升原因尚不清楚。多项研究报告了广泛使用的镇痛药对乙酰氨基酚与确诊哮喘之间的关联。在一项前瞻性队列研究中,多变量分析显示,频繁使用对乙酰氨基酚的人群中新诊断哮喘的发生率比不使用者高63%。对哮喘患者的研究表明,对乙酰氨基酚激发试验可使敏感个体的第一秒用力呼气容积(FEV₁)下降超过15%。解释这种关联的可能机制包括肺内谷胱甘肽耗竭和氧化应激。本文回顾了现有文献,并评估了对乙酰氨基酚与哮喘之间可能联系的流行病学和病理生理学证据。